MAT

Report: Retail Investors Aren't Slowing Down in 2023, Embracing Diversified Investing Strategies

Retrieved on: 
Wednesday, August 30, 2023
Learning, ETF, University, AB InBev, NVDA, AB, Research, Appetite, SMU, Law school, Pageview, Economics, Trust, Friction, AUM, MAT, GM, Investment, BUD, Risk, University of Missouri–Kansas City School of Law, UAB Institute of Law and Technology, Artificial intelligence, Yoy, Growth, ESG, Entrepreneurship, AI, Bud Light Daredevils, Corporate law, Social media, Treasury, Qualitative research, Financial adviser, Cryptocurrency, Security (finance), Public utility, Nvidia, Mattel

NEW YORK, Aug. 30, 2023 /PRNewswire/ -- Public, an investing platform that lets members Invest in stocks, Treasuries, ETFs, crypto, and alternative assets with deep fundamental data and custom analysis powered by AI, surveyed 2,000+ retail investors and reviewed investing flows throughout the year to compile its 1H 2023 report. Key findings from the report highlight investors are remaining active in the markets this year but are shifting their strategies. In 2023, more investors are focusing on due diligence and research, using artificial intelligence to inform investment decisions, and diversifying into fixed income products.

Key Points: 
  • Key findings from the report highlight investors are remaining active in the markets this year but are shifting their strategies.
  • 19% of retail investors already use AI for investment research, with most holdouts being investors interested in learning how to leverage AI to inform their portfolio strategies.
  • Retail investor engagement remains strong in 2023, with investors focusing more on diversifying their investment strategies and looking at fixed income.
  • This report offers a directional perspective on the retail investor market, drawing from Public's community of investors.

Pinnacle Treatment Centers to host Grand Opening celebration for Winchester Treatment Services

Retrieved on: 
Monday, August 28, 2023
Other Health, Hospitals, Health, Pharmaceutical, Managed Care, Parent, Methadone, Pregnancy, OTP, Grief, FDA, MAT, Opioid, Heroin, Senior counsel, Pharmaceutical industry

One of Pinnacle’s 8 opioid treatment programs (OTP) in the state , Winchester Treatment Services provides medication-assisted treatment (MAT), particularly methadone and suboxone, coupled with various methods of counseling and behavioral therapies at the facility.

Key Points: 
  • One of Pinnacle’s 8 opioid treatment programs (OTP) in the state , Winchester Treatment Services provides medication-assisted treatment (MAT), particularly methadone and suboxone, coupled with various methods of counseling and behavioral therapies at the facility.
  • MAT is the gold standard of care for opioid addiction.
  • The FDA-approved medicines work to curb withdrawal symptoms from heroin and pain pill addiction, prevent relapse, and help ease the physical discomfort that accompanies opioid recovery.
  • Individuals needing addiction treatment can call (859) 287-1098 for a free, confidential assessment.

Mattel to Participate in the Goldman Sachs Communacopia and Technology Conference

Retrieved on: 
Tuesday, August 22, 2023
Toys, Entertainment, Retail, Consumer, Children, Licensing (Entertainment), Offshore Technology Conference, Webcast, Mattel Inc v 3894207 Canada Inc, MAT, Conference, Cryptocurrency, Broadcasting

Mattel, Inc. (NASDAQ: MAT) today announced that Ynon Kreiz, Mattel’s Chairman and Chief Executive Officer, and Anthony DiSilvestro, Mattel’s Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Communacopia and Technology Conference on Thursday, September 7 at 12:30 p.m. Eastern time.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that Ynon Kreiz, Mattel’s Chairman and Chief Executive Officer, and Anthony DiSilvestro, Mattel’s Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Communacopia and Technology Conference on Thursday, September 7 at 12:30 p.m. Eastern time.
  • The webcast will be available on Mattel’s Investor Relations website, https://investors.mattel.com/ under ‘Events and Presentations.’ To listen to the webcast, log onto the website at least 15 minutes early to register, download, and install any necessary software.
  • An archive of the webcast will be available on the Company’s website shortly after the completion of the live webcast.

Spark Biomedical Launches Telehealth Services for Sparrow Ascent, Improving Patient Access to Opioid Withdrawal Treatment

Retrieved on: 
Tuesday, August 8, 2023
Partnership, Friction, MAT, Drug, Patient, Physician, FDA, Empowerment, Caregiver, Birth control, Pharmaceutical industry, Medical device, Nursing

August 8, 2023, Dallas, TX (GLOBE NEWSWIRE) --  Spark Biomedical Inc., a U.S. leader in wearable neurostimulation solutions, is proud to announce the launch of telehealth services for their recently FDA-cleared product, Sparrow Ascent. Through partnership with existing telehealth networks, Sparrow Ascent can now be prescribed and e-prescriptions administered all via remote patient access. Sparrow Ascent— a safe, drug-free opioid withdrawal treatment — provides a much-needed treatment option to patients seeking to decrease or eliminate their reliance on opioids and who can or won't access facility-directed care. Pairing Sparrow Ascent and the telehealth home-based treatment option, the journey to recovery can now be more comfortable, more flexible, and more accessible, empowering patients to take the first critical step toward recovery.

Key Points: 
  • DALLAS, TX, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Spark Biomedical Launches Telehealth Services for Sparrow Ascent, Improving Patient Access to Opioid Withdrawal Treatment
    August 8, 2023, Dallas, TX (GLOBE NEWSWIRE) --  Spark Biomedical Inc., a U.S. leader in wearable neurostimulation solutions, is proud to announce the launch of telehealth services for their recently FDA-cleared product, Sparrow Ascent.
  • Through partnership with existing telehealth networks, Sparrow Ascent can now be prescribed and e-prescriptions administered all via remote patient access.
  • Sparrow Ascent— a safe, drug-free opioid withdrawal treatment — provides a much-needed treatment option to patients seeking to decrease or eliminate their reliance on opioids and who can or won't access facility-directed care.
  • With the launch of telehealth services for Sparrow Ascent, Spark Biomedical is transforming the landscape of opioid withdrawal treatment, offering hope and empowerment to patients across the nation.

Mortgage Automation Technologies Introduces Halcyon Direct to Consumer Integration to The BIG Point of Sale Solution

Retrieved on: 
Thursday, August 3, 2023
IRS, LPA, AIM, PDF, POS, Marriage, Point, Sale, App Store (iOS/iPadOS), Big Point, Mississippi, MAT, API, IRS tax forms, Melia, Online shopping, Cryptocurrency, Halcyon

The BIG Point of Sale and Halcyon collaborated to build the integration of their products on the latest loan origination system APIs.

Key Points: 
  • The BIG Point of Sale and Halcyon collaborated to build the integration of their products on the latest loan origination system APIs.
  • With the Halcyon integration, The BIG Point of Sale has built a module allowing consumers to electronically sign IRS authorization documents from their mobile devices.
  • Additionally, utilizing The BIG Point of Sale and Halcyon integration, the IRS data is passed directly back to loan level-fields within the loan origination system.
  • "We are excited to work with The BIG Point of Sale team to provide our ground-breaking income verification solution directly to the consumer workflow," said Kirk Donaldson, CEO of Halcyon.

Fisher-Price® Introduces New Sensory Bright™ Line—Inspiring Kids 3 and Up to Custom-Create Their Own Sensory Experience That’s as Unique as They Are

Retrieved on: 
Monday, July 31, 2023
Children, Primary, Secondary, Education, Specialty, Women, Preschool, Retail, Toys, Family, Consumer, Parenting, Smell, Music, Parent, Light, Multimedia, Brain, Fisher-Price, Target, Creativity, MAT, Child, Sound, System, Sensory, Caregiver, Toy, Lobster

Designed to encourage exploration, problem-solving, and creativity, the new line includes the following four complementary products: Fisher-Price® Sensory Bright™ Light Station; Fisher-Price® Sensory Bright™ SpinnyScopes™; Fisher-Price® Sensory Bright™ Squish Scape™; and Fisher-Price® Sensory Bright™ Squeeze ‘n Sniffs.

Key Points: 
  • Designed to encourage exploration, problem-solving, and creativity, the new line includes the following four complementary products: Fisher-Price® Sensory Bright™ Light Station; Fisher-Price® Sensory Bright™ SpinnyScopes™; Fisher-Price® Sensory Bright™ Squish Scape™; and Fisher-Price® Sensory Bright™ Squeeze ‘n Sniffs.
  • Available exclusively at Target, all of the new items can be played with on their own or added to the light station for even more ways to enhance the sensory experience.
  • Fisher-Price Sensory Bright Squish Scape , ($11.99): Set the scene for under-the-sea sensory discoveries with this mess-free, squish scape tablet.
  • The Fisher-Price Sensory Bright Line is available today exclusively at Target online and in-store.

Mattel Announces Departure of Richard Dickson, President and Chief Operating Officer

Retrieved on: 
Wednesday, July 26, 2023
Retail, Entertainment, Toys, Licensing (Entertainment), Partnership, Doll, Senior, Final good, McKnight, The Walt Disney Company, Disney Princess, IP, Hasbro, Mattel Inc v 3894207 Canada Inc, Publishing, MAT, Monster High, Atari Interactive, Growth, Management, Toy, Mattel

Mattel, Inc. (NASDAQ: MAT) today announced that Richard Dickson, President and Chief Operating Officer, will step down from his position with the Company effective August 3, 2023 to take the role of president and chief executive officer at another public company.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that Richard Dickson, President and Chief Operating Officer, will step down from his position with the Company effective August 3, 2023 to take the role of president and chief executive officer at another public company.
  • Josh Silverman has been promoted to Executive Vice President and Chief Franchise Officer.
  • Both executives will assume Dickson’s responsibilities and report to Ynon Kreiz, Chairman and Chief Executive Officer of Mattel.
  • The company has also promoted Chris Down to Executive Vice President and Chief Design Officer, reporting to McKnight.

Mattel Renews Licensing Partnership with Warner Bros. Discovery Global Consumer Products

Retrieved on: 
Tuesday, July 25, 2023
Department Stores, Entertainment, Public Relations, Investor Relations, Toys, Online, Communications, General Entertainment, Film & Motion Pictures, Retail, Online Retail, Universe, Warner, FRIENDS, Partnership, Senior, Marketing, DC Universe, Warner Bros. Discovery, Mattel Inc. v. Walking Mountain Prods., MAT, Imaginext, Warner Bros., Warner Bros. Discovery Global Brands and Experiences, Ted Lasso, Amusement park, Mattel

Mattel, Inc. (NASDAQ: MAT) today announced that it has renewed its licensing agreement with Warner Bros.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that it has renewed its licensing agreement with Warner Bros.
  • Discovery Global Consumer Products.
  • Mattel will continue as a Warner Bros.’ toy licensee for the preschool, plush, dolls, vehicles, games, and novelty toy categories, developing and marketing products for more than 50 Warner Bros.
  • Discovery Global Consumer Products can be found here .

Discovery Behavioral Health announces the opening of Horizon Hills, a residential treatment center in Malibu for substance use disorder offering luxury accommodations for treatment and medically-assisted detox

Retrieved on: 
Wednesday, July 12, 2023
Yoga, Acupuncture, Eating disorder, DBH, Privacy, Massage, MAT, Cliffside Malibu, Patient, Stress, Relaxation, Cliffside, Addiction, Pharmaceutical industry

LOS ANGELES, July 12, 2023 /PRNewswire/ -- Discovery Behavioral Health, Inc., an expanding network of evidence-based mental health, substance use and eating disorder treatment centers announces the opening of its latest residential facility, Horizon Hills, located in the Los Angeles beachside community of Malibu.

Key Points: 
  • LOS ANGELES, July 12, 2023 /PRNewswire/ -- Discovery Behavioral Health, Inc. , an expanding network of evidence-based mental health, substance use and eating disorder treatment centers announces the opening of its latest residential facility, Horizon Hills , located in the Los Angeles beachside community of Malibu.
  • The new center offers medically assisted detox (MAT) and is part of DBH's Cliffside Malibu brand of luxury residential treatment centers, which also includes Sunset Malibu and Big Horizon properties.
  • Cliffside Malibu is internationally known for its innovative, evidence-based treatment for alcohol and drug addiction.
  • In addition to beautifully appointed private rooms, a private casita is available, complete with living room, bedroom, kitchen, laundry and 180-degree ocean views for those who desire a heightened level of privacy and luxury.

Dimagi Expands Global Public and Community Health Technology Across U.S.

Retrieved on: 
Tuesday, July 11, 2023
Acumen, Workforce, Contact tracing, Foundation (nonprofit), Rockefeller Foundation, PATH, Navajo Nation, VDOT, Public, Health equity, Data collection, RCS, MIT, World Bank, UNICEF, CDC, Harvard Medical School, Organization, Navajo, World Vision International, MAT, Non-governmental organization, COVID-19, Tuberculosis, Harvard Medical School Center for Health and the Global Environment, Case management, Bill, Acumen (organization), Health, Bill & Melinda Gates Foundation, USAID, NIH, World Health Organization, Pharmaceutical industry, Nursing, Dimagi

CAMBRIDGE, Mass., July 11, 2023 /PRNewswire/ -- Dimagi, a technology partner for public and community health, has announced an expansion of its globally-acclaimed products and services across the United States. Dimagi's flagship product, CommCare, which has been developed and refined through 3,000+ successful global projects with international governments and NGOs, will now be widely available to support pressing and complex public and community health initiatives across the U.S.

Key Points: 
  • CommCare was first offered to the U.S. market during the Covid-19 pandemic and is now available to support organizations in a broad array of public and community health initiatives.
  • When partnered with agencies and organizations, CommCare enables programs across behavioral and public health providing solutions for bed and patient tracking, care coordination, provider directories and referral systems.
  • Founded in 2002 out of MIT and Harvard Medical School's joint division Health Science Tech, Dimagi was among the first Certified B Corporations established in Massachusetts.
  • SureAdhere is currently deployed in Vermont and Illinois as a VDOT tool for Medication-Assisted Treatment (MAT), with an additional 388 county public health agencies across 18 states utilizing SureAdhere for tuberculosis treatment support.